Graviti Pharmaceuticals Private Limited recalls Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ
Graviti Pharmaceuticals recalls 10mg Atorvastatin tablets due to customer reports of foreign tablets in some bottles. Affected units may contain 20mg tablets instead of 10mg.
Lower-risk recall
Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
Contact the company & request your remedy
What happened, in plain English
Graviti Pharmaceuticals is recalling 10mg Atorvastatin Calcium tablets because some bottles contain 20mg tablets instead of the labeled 10mg. This could lead to incorrect dosing if taken without knowing the actual strength. Read more at govinfonow.com/recall/37395-grav-atorvastatin-10mg-tablets-recall-due-to-foreign-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/37395-grav-atorvastatin-10mg-tablets-recall-due-to-foreign-tablets · Updated October 5, 2026 · FDA enforcement record: FDA #D-0832-2020
Cite this page
“Grav: Atorvastatin 10mg Tablets Recall Due to Foreign Tablets.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37395-grav-atorvastatin-10mg-tablets-recall-due-to-foreign-tablets. Based on FDA recall #D-0832-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0832-2020%22&limit=1).
Why it’s dangerous
The recall is based on customer complaints that some bottles contain 20mg tablets instead of the labeled 10mg tablets. This could cause incorrect dosing if the patient takes the tablets without realizing the higher strength.
Who’s affected
Prescription users of Atorvastatin 10mg tablets in the US who received bottles labeled as 10mg but contain 20mg tablets. Patients taking the medication as prescribed are most at risk of incorrect dosing.
How to tell if you have this one
Check for bottles labeled 'Atorvastatin Calcium Tablets, USP, 10 mg' with NDC 70377-027-11. The affected lot number is ATA318099C, which expired December 2020.
- Brand
Graviti Pharmaceuticals- Category
Drug
What to do — step by step
Check Your Bottle
Look for bottles labeled 'Atorvastatin Calcium Tablets, USP, 10 mg' with NDC 70377-027-11 and lot number ATA318099C.
Questions people ask
Why is this recall happening?
Customer complaints reported that some bottles contain 20mg tablets instead of the labeled 10mg tablets.
How can I tell if my bottle is affected?
Check for bottles labeled 'Atorvastatin Calcium Tablets, USP, 10 mg' with NDC 70377-027-11 and lot number ATA318099C.
What should I do if I have the affected bottle?
The recall does not specify a remedy, so contact your healthcare provider for advice on whether to stop using the medication.
Contact Graviti Pharmaceuticals
We’ve drafted a message you can send Graviti Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0832-2020 — Graviti Pharmaceuticals Graviti Pharmaceuticals Hello, I own a Graviti Pharmaceuticals that is covered by recall D-0832-2020 from Graviti Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0832-2020 (January 28, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0832-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.